Utah People's Post

The Latest News from the Beehive State

Tuesday, December 5, 2023
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / Fujifilm’s Avigan May Receive Approval for Ebola Treatment This Year

Fujifilm’s Avigan May Receive Approval for Ebola Treatment This Year

November 11, 2014 Posted by Contributor

JAPAN-HEALTH-EBOLA-PHARMA-FUJIFILMAvigan, the influenza drug which showed promise in the treatment of Ebola patients, might receive approval by the end of 2014, Fujifilm Holdings Corp announced.

Fujifilm’s pharmaceutical division has been growing despite a tiresome series of mergers and acquisitions while its photography business wanes. Toyama Chemical Co. was one of Fujifilm’s most inspired acquisitions in 2008, and Avigan, the company’s influenza drug, might become the number one tool in the fight against Ebola.

In Japan, the drug has been approved to counter different forms of influenza. However, clever doctors decided to take a risk and treat Ebola patients with the same substance. In countries such as France, Norway, Germany and Spain, patients received this somewhat unorthodox treatment. And since Fujifilm’s stockpile is more than enough to treat 20,000 patients (with the possibility of mass producing enough tablets to treat an additional 30,000), the situation is looking bright.

“So far, four Ebola patients have recovered after being treated with the drug,”

Shigetaka Komori, Fujifilm Chairman and Chief executive, informed Japanese reporters on Tuesday.

This month, France and Guinea are already prepared to begin clinical trials of Avigan 200 mg tablets to treat Ebola patients located in the country worst stricken by the outbreak. If after this one-month trial, the drug proves effective, it will most likely receive its approval in the treatment of Ebola by the end of the year.

“Ebola is a threat to international peace and stability. Japan will add up to $100 million in aid, on top of $40 million already announced,”

Japan’s Prime Minister, Shinzo Abe said, announcing his full support in the fight against the Ebola outbreak. He was pleased to hear that a drug produced by a Japanese drugmaker was showing so much promise and insisted that his government was prepared to make significant contributions on this front.

After information about the company’s promising drug was released, Fujifilm’s stocks rose 3.2 percent on Tuesday, to 3,837 yen, their highest level since May 2008. In the future, the company plans to invest anywhere between 400 and 500 billion yen in deals to strengthen its healthcare operations. By the end of March 2017, Fujifilm expects 220 billion yen in operating profit.

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health Tagged With: avigan, avigan approval, avigan ebola, Ebola, ebola treatment, France, fujifilm, guinea, Influenza, influenza drug, treatment of ebola

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

June 29, 2018 By Amelia Donovan

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

June 29, 2018 By Amelia Donovan

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

June 28, 2018 By Amelia Donovan

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

June 27, 2018 By Amelia Donovan

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

June 27, 2018 By Amelia Donovan

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

June 26, 2018 By Amelia Donovan

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

June 25, 2018 By Amelia Donovan

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

June 23, 2018 By Amelia Donovan

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

June 22, 2018 By Amelia Donovan

456 People Dead at U.K. Hospital after Taking too Many Painkillers

June 21, 2018 By Amelia Donovan

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

June 20, 2018 By Amelia Donovan

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

    Jun 29, 2018
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

    Jun 29, 2018
  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

    Jun 27, 2018
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

    Jun 25, 2018
  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

    Jun 22, 2018
  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

    Jun 21, 2018
  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

    Jun 19, 2018
  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

    Jun 18, 2018
  • Our Brains Are Craving Combinations of Fats and Carbs (Study)

    Jun 15, 2018
  • Hungry bird with beck open

    Scientists Explain Why We Get ‘Hangry’

    Jun 13, 2018

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2023 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact